Comparison of Metabolites and Gut Microbes between Patients with Parkinson’s Disease and Healthy Individuals—A Pilot Clinical Observational Study (STROBE Compliant)

Introduction: Even if levodopa, dopamine agonists, and others are used for patients with Parkinson’s disease, the effect is not sustained, and side effects such as motor fluctuation and dyskinesia are more likely to appear as the dose increases. Thus, new approaches for managing Parkinson’s disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Cheol-Hyun, Jung, Jeeyoun, Lee, Young-ung, Kim, Kwang-ho, Kang, Sunny, Kang, Geon-hui, Chu, Hongmin, Kim, Se-Young, Lee, Sangkwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871597/
https://www.ncbi.nlm.nih.gov/pubmed/35206916
http://dx.doi.org/10.3390/healthcare10020302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871597/
https://www.ncbi.nlm.nih.gov/pubmed/35206916
http://dx.doi.org/10.3390/healthcare10020302

Ejemplares similares